Lung squamous cell carcinoma with severe hypomagnesemia due to cisplatin plus gemcitabine in combination with necitumumab therapy: A case report
Author:
Affiliation:
1. Department of Respiratory Medicine Fukuoka University Hospital Fukuoka Japan
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine,Oncology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13999
Reference13 articles.
1. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first‐line therapy in patients with stage IV squamous non‐small‐cell lung cancer (SQUIRE): An open‐label, randomised, controlled phase 3 trial;Thatcher N;Lancet Oncol,2015
2. Short‐term impacts of sodium/glucose co‐transporter 2 inhibitors in Japanese clinical practice: Considerations for their appropriate use to avoid serious adverse events;Yabe D;Expert Opin Drug Saf,2015
3. The effect of advances in lung‐cancer treatment on population mortality;Howlader N;N Engl J Med,2020
4. Pembrolizumab plus chemotherapy for squamous non–small‐cell lung cancer;Paz‐Ares L;N Engl J Med,2018
5. Updated analysis of KEYNOTE‐024: Pembrolizumab versus platinum‐based chemotherapy for advanced non‐small‐cell lung cancer with PD‐L1 tumor proportion score of 50% or greater;Reck M;J Clin Oncol,2019
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Monoclonal antibodies for the treatment of squamous cell carcinoma: A literature review;Cancer Reports;2023-04-12
2. Targeted therapy;Medicines for Cancer;2023
3. Necitumumab plus gemcitabine and cisplatin in previously treated lung squamous cell carcinoma;Investigational New Drugs;2022-11-04
4. Cisplatin/gemcitabine/necitumumab;Reactions Weekly;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3